Paper
RSC Advances
mmol), AgOH (684 mg, 5.48 mmol) and D-tartaric acid (342
(IC2) m/z 149. Anal calc. for C30H48N2O6 + 3.5 H2O C 60.48 H
9.31 N 4.70%; found C 60.24 H 9.67 N 4.70%.
1-Octylpyridinium L-tartrate, [OctPyr]2L-Tart, (+)-3b: pre-
pared as its enantiomer; it displayed analytical data identical
to that of the D-isomer. [a]2D0 +9.5 (c 0.98, H2O).
1-Octylpyridinium DL-tartrate, [OctPyr]2DL-Tart, rac-3b: pre-
pared following method B using [OctPyr]Br (1.00 g, 3.67
mmol), AgOH (550 mg, 4.41 mmol) and DL-tartaric acid (276
mg, 1.84 mmol). The salt rac-3b was obtained as a viscous pale
yellow oil (931 mg, 95%). This compound displayed anaytical
data identical to that of its D- or L-stereoisomer. Anal calc. for
C30H48N2O6 + 4.25 H2O C 59.14 H 9.35 N 4.60%; found C 59.33
H 9.43 N 4.64%.
mg, 2.28 mmol). The salt (2)-1b was obtained as a viscous pale
1
yellow oil (904 mg, 93%). [a]2D0 210 (c 0.7, H2O). H-NMR (300
MHz, D2O) d 8.70 (s, 2H), 7.46 (d, J = 1.9 Hz, 2H), 7.42 (d, J = 1.9
Hz, 2H), 4.29 (s, 2H), 4.18 (t, J = 7.1 Hz, 4H), 3.88 (s, 6H), 1.90–
1.75 (m, 4H), 1.38–1.21 (m, 4H), 0.91 (t, J = 7.4 Hz, 6H). 13C-
NMR (75 MHz, D2O) d 178.3, C-2 non apparent, 123.4, 123.4,
122.2, 122.1, 73.8, 49.2, 35.5, 31.2, 18.7, 12.6. ATR-FTIR n 3389,
3148, 3102, 2962, 2936, 2875, 1603, 1466, 1352, 1170, 1115,
1062 cm21. MS (IC+) m/z 139; (IC2) m/z 149. Anal calc. for
C20H34N4O6 + 3 H2O C 49.99 H 8.39 N 11.66%; found C 49.71 H
8.52 N 11.67%.
1-Butyl-3-methylimidazolium L-tartrate, [Bmim]2L-Tart, (+)-
1b: prepared as its enantiomer; it displayed analytical data
identical to that of the D-isomer. [a]2D0 +10 (c 1.0, H2O) (litt.15
[a]2D0 +11.7 (c 1, H2O).
1-Butyl-3-methylimidazolium meso-tartrate, [Bmim]2meso-
Tart, meso-1b: prepared following method A using meso-
tartaric acid (1.12 g, 6.66 mmol), Ag2CO3 (1.84 g, 6.67 mmol)
and [Bmim]Br (2.92 g, 13.3 mmol). The salt meso-1b was
obtained as a white solid (2.61 g, 92%). 1H-NMR (300 MHz,
CD3OD) d 9.05 (s, nH), 7.62 (d, J = 1.9 Hz, 2H), 7.57 (d, J = 1.9
Hz, 2H), 4.23 (t, J = 7.3 Hz, 4H), 4.11 (s, 2H), 3.94 (s, 6H), 1.80–
1.94 (m, 4H), 1.45–1.32 (m, 4H), 0.99 (t, J = 7.3 Hz, 6H). 13C-
NMR (75 MHz, CD3OD) d 178.3, 138.1, 124.9, 123.5, 76.1, 50.5,
36.5, 33.1, 20.5, 13.8. ATR-FTIR n 3367, 3144, 3088, 2961, 2933,
2874, 1608, 1571, 1465, 1406, 1365, 1348, 1172, 1108, 1061
cm21. MS (IC+) m/z 139; (IC2) m/z 149. Anal calc. for
C20H34N4O6 + 3.5 H2O C 49.07 H 8.44 N 11.44%; found C
48.82 H 8.60 N 11.33%.
1-Octylpyridinium meso-tartrate, [OctPyr]2meso-Tart, meso-
3b: This compound was prepared following method B using
[OctPyr]Br (1.00 g, 3.67 mmol), AgOH (550 mg, 4.41 mmol) and
meso-tartaric acid (276 mg, 1.84 mmol). The salt meso-3b was
1
obtained as a viscous pale yellow oil (921 mg, 94%). H-NMR
(300 MHz, CD3OD) d 9.02 (d, J = 5.6 Hz, 4H), 8.60 (tt, J = 7.8, 1.1
Hz, 2H), 8.13 (t, J = 7.0 Hz, 4H), 4.64 (t, J = 7.6 Hz, 4H), 4.12 (s,
2H), 2.02 (quintuplet, J = 7.0 Hz, 4H), 1.49–1.21 (m, 20H), 0.90
(t, J = 7.2 Hz, 6H). 13C-NMR (75 MHz, CD3OD) d 178.2, 146.8,
145.1, 129.6, 76.0, 63.2, 63.1, 32.9, 32.6, 30.2, 30.1, 27.2, 23.7,
14.4. ATR-FTIR n 3391, 3126, 3059, 2955, 2927, 2856, 1608,
1488, 1467, 1358, 1223, 1177, 1109, 1072 cm21. MS (IC+) m/z
192; (IC2) m/z 149. Anal calc. for C30H48N2O6 + 5.25 H2O C
57.44 H 9.40 N 4.47%; found C 57.32 H 9.43 N 4.60%.
Tetrabutylammonium D-tartrate, [TBA]2D-Tart, (2)-4b: pre-
pared following method B using [TBA]Br (1.00 g, 3.10 mmol),
AgOH (465 mg, 3.72 mmol) and D-tartaric acid (233 mg, 1.55
mmol). The salt (2)-4b was obtained as colourless wax (932
mg, 95%). [a]2D0 28.5 (c 0.88, H2O). 1H-NMR (300 MHz, CD3OD)
d 4.31 (s, 2H), 3.27–3.21 (m, 16H), 1.72–1.60 (m, 16H), 1.42
(sextuplet, J = 7.3 Hz, 16H), 1.03 (t, J = 7.3 Hz, 24H). 13C-NMR
(75 MHz, CD3OD) d 179.0, 75.1, 59.5, 24.8, 20.7, 13.9. ATR-FTIR
n 3377, 2960, 2936, 2875, 1603, 1487, 1461, 1380, 1348, 1109,
1060, 1029 cm21. MS (IC+) m/z 242; (IC2) m/z 149. Anal calc.
for C36H76N2O6 + 2.5 H2O C 63.77 H 12.04 N 4.13%; found C
63.49 H 12.07 N 4.38%.
1-Butyl-2,3-dimethylimidazolium D-tartrate, [Bmmim]2D-
Tart, (2)-2b: prepared following method B using [Bmmim]Br
(1.00 g, 4.29 mmol), AgOH (643 mg, 5.15 mmol) and D-tartaric
acid (322 mg, 2.15 mmol). The salt (2)-2b was obtained as a
1
pale yellow solid (928 mg, 95%). [a]2D0 29.5 (c 0.95, H2O). H-
NMR (300 MHz, CD3OD) d 7.51 (d, J = 2.1 Hz, 2H), 7.48 (d, J =
2.1 Hz, 2H), 4.28 (s, 2H), 4.15 (t, J = 7.4 Hz, 4H), 3.82 (s, 6H),
2.62 (s, 6H), 1.88–1.73 (m, 4H), 1.48–1.31 (m, 4H), 0.99 (t, J =
7.3 Hz, 6H). 13C-NMR (75 MHz, CD3OD) d 179.0, 145.8, 123.7,
122.2, 75.1, 49.8, 35.4, 32.8, 20.5, 13.9, 9.5. ATR-FTIR n 3387,
3138, 2962, 2935, 2875, 1605, 1540, 1465, 1420, 1351, 1251,
1114, 1061 cm21. MS (IC+) m/z 153; (IC2) m/z 149. Anal calc.
for C22H38N4O6 + 2 H2O C 53.86 H 8.63 N 11.42%; found C
53.60 H 9.08 N 11.30%.
1-Butyl-2,3-dimethylimidazolium L-tartrate, [Bmmim]2L-
Tart, (+)-2b: prepared as its enantiomer; it displayed analytical
data identical to that of the D-isomer. [a]2D0 +9.5 (c 1.0, H2O).
1-Octylpyridinium D-tartrate, [OctPyr]2D-Tart, (2)-3b: pre-
pared following method B using [OctPyr]Br (1.00 g, 3.67
mmol), AgOH (550 mg, 4.41 mmol) and D-tartaric acid (276
mg, 1.84 mmol). The salt (2)-3b was obtained as a viscous pale
yellow oil (931 mg, 95%). [a]2D0 29.5 (c 0.99, H2O). 1H-NMR (300
MHz, CD3OD) d 9.02 (d, J = 5.6 Hz, 4H), 8.60 (tt, J = 7.8, 1.1 Hz,
2H), 8.13 (t, J = 6.9 Hz, 4H), 4.64 (t, J = 7.6 Hz, 4H), 4.32 (s, 2H),
2.02 (quintuplet, J = 7.0 Hz, 4H), 1.48–1.21 (m, 20H), 0.90 (t, J =
7.0 Hz, 6H). 13C-NMR (75 MHz, CD3OD) d 179.0, 146.8, 146.0,
129.5, 75.1, 63.1, 32.9, 32.5, 30.2, 30.1, 27.2, 23.6, 14.4. ATR-
FTIR n 3388, 3129, 3090, 3063, 2955, 2927, 2857, 1634, 1604,
1489, 1467, 1353, 1177, 1118, 1067 cm21. MS (IC+) m/z 192;
Tetrabutylammonium L-tartrate, [TBA]2L-Tart, (+)-4b: pre-
pared as its enantiomer; it displayed analytical data identical
to that of that of the D-isomer. [a]2D0 +8.5 (c 1.2, H2O). Selected
crystal data for [TBA]2L-Tar (+)-4b: C36H90N2O13, M = 759.10,
Monoclinic, space group P21, a = 9.5730(5) Å, b = 15.2408(9) Å,
c = 16.3095(10) Å, V = 2378.1(2) Å3, Z = 2, crystal size 0.60 6
0.10 6 0.10 mm3, 18 337 reflections collected (8021 indepen-
dent, Rint = 0.0338), 534 parameters, 69 restraints, R1 [I . 2s(I)]
= 0.0625, wR2 [all data] = 0.1808, largest diff. peak and hole:
0.388 and 20.224 e Å23
.
1-Butyl-1-methyl pyrrolidinium D-tartrate, [Bmpyr]2D-Tart,
(2)-5b: prepared following method B using [Bmpyr]Br (1.00 g,
4.5 mmol), AgOH (674 mg, 5.4 mmol) and D-tartaric acid (338
mg, 2.25 mmol). The salt (2)-5b was obtained as a white solid
(895 mg, 92%). [a]2D0 211 (c 0.99, H2O). 1H-NMR (300 MHz,
D2O) d 4,31 (s, 2H), 3.59–3.42 (m, 8H), 3.39–3.22 (m, 4H), 3,02
(s, 6H), 2.25–2.12 (m, 8H), 1.84–1.65 (m, 4H), 1.38 (sextuplet, J
= 7.4 Hz, 4H), 0.94 (t, J = 7.4 Hz, 6H). 13C-NMR (75 MHz, D2O) d
178.0, 75.2, 65.3, 48.8, 26.6, 22.5, 20.7, 14.1. ATR-FTIR n 3334,
3021, 2963, 2933, 2874, 1607, 1469, 1357, 1124, 1061 cm21. MS
424 | RSC Adv., 2013, 3, 413–426
This journal is ß The Royal Society of Chemistry 2013